Literature DB >> 8611362

Hemolytic uremic syndrome in families-an Argentinian experience.

L E Voyer1, R E Wainsztein, B E Quadri, S E Corti.   

Abstract

Six hundred and thirty-one patients with hemolytic uremic syndrome (HUS) were treated from 1960 to 1992; 19 (3%) were familial cases, of which 9 were classified as concomitant (including twins), 6 as non-concomitant, and 4 as recurrent. In the recurrent group there were 15 HUS episodes, 10 being concomitant in 2 patients. Prodromal diarrhea was present only in concomitant and non-concomitant cases. Patients with recurrences were sisters from a single family. Concomitant and non-concomitant cases had clinical features, course, and age similar to typical endemoepidemic forms of HUS, in which an association with verocytotoxin-producing Escherichia coli has been reported. There may be a genetic determinant in concomitant cases; these occurred outside the season during which endemoepidemic forms are typically detected. In patients with recurrent disease a genetic factor which may lead to the development of the disease when triggered by viral infections is likely.

Entities:  

Mesh:

Year:  1996        PMID: 8611362     DOI: 10.1007/bf00863451

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

2.  Familial, recurrent haemolytic-uraemic syndrome with hypocomplementaemia.

Authors:  J Zachwieja; K Strzykala; W Golda; J Maciejewski
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

3.  [Detection of verotoxin-producing Escherichia coli O157 in patients with hemolytic uremic syndrome].

Authors:  M Rivas; L E Voyer; M I Tous; N A Leardini; M F de Mena; B Quadri; R Wainsztein
Journal:  Medicina (B Aires)       Date:  1990       Impact factor: 0.653

4.  Haemolytic uraemic syndrome associated with faecal cytotoxin and verotoxin neutralizing antibodies.

Authors:  A A Novillo; L E Voyer; R Cravioto; M C Freire; G Castaño; R Wainstein; N Binztein
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

5.  The hemolytic-uremic syndrome is a syndrome.

Authors:  B S Kaplan; K N Drummond
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

6.  Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood.

Authors:  K A Jørgensen; R S Pedersen
Journal:  Thromb Res       Date:  1981-02-01       Impact factor: 3.944

7.  Hemolytic uremic syndrome with recurrent episodes: an important subset.

Authors:  B S Kaplan
Journal:  Clin Nephrol       Date:  1977-12       Impact factor: 0.975

Review 8.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

9.  Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.

Authors:  E L Lopez; M Diaz; S Grinstein; S Devoto; F Mendilaharzu; B E Murray; S Ashkenazi; E Rubeglio; M Woloj; M Vasquez
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

10.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

View more
  1 in total

1.  Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2012-04-03       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.